Titel

Merkliste
1 Ergebnisse

P634 Ustekinumab and vedolizumab as first-line biological t..:

Calafat Sard, M ; Pascual, I ; Nos, P...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i766-i767 , 2023

Link: https://doi.org/10.1093/ecco-jcc/jjac190.0764

RT Journal
T1 <Title>P634 Ustekinumab and vedolizumab as first-line biological therapy for inflammatory bowel disease. A multicenter study based on the ENEIDA registry</Title>

UL https://suche.suub.uni-bremen.de/peid=cr-10.1093_ecco-jcc_jjac190.0764&Exemplar=1&LAN=DE
				
A1 Calafat Sard, M
A1 Pascual, I
A1 Nos, P
A1 Barrio, J
A1 Gutiérrez, A
A1 Martín-Arranz, M D
A1 Ricart, E
A1 Gomollón, F
A1 Sierra Ausín, M
A1 Huguet, J M
A1 Guardiola, J
A1 Vera, I
A1 Varela, P
A1 Iglesias, E
A1 Garcia-Planella, E
A1 de Castro, L
A1 García Sepulcre, M F
A1 Sicilia, B
A1 Fernández-Salazar, L
A1 Calvet, X
A1 Muñoz, F
A1 García-López, S
A1 Bermejo, F
A1 Ramos, L
A1 Martínez Montiel, P
A1 Lorente, R
A1 Cabriada, J L
A1 Piqueras, M
A1 Marín-Jiménez, I
A1 Esteve, M
PB Oxford University Press (OUP)
YR 2023
SN 1873-9946
SN 1876-4479
JF Journal of Crohn's and Colitis
VO 17
IS Supplement_1
SP i766
OP i767
LK http://dx.doi.org/https://doi.org/10.1093/ecco-jcc/jjac190.0764
DO https://doi.org/10.1093/ecco-jcc/jjac190.0764
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)